Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pfenex
More »

  • GEN | Biolinks
    ... BV PEPTONIC Medical AB Pergamum AB Perkin Elmer Pfenex Pfenex Inc Pfizer Inc Pharma Industry Finland - PIF pharmaCline PharmAthene, Inc PhaseBio Pharmaceuticals, Inc Phigenix, Inc. ...
  • Pfenex and Agila Biotech Target Biosimilars
    Pfenex and Agila Biotech entered into a joint venture to develop, manufacture, and ... Human clinical trials are expected to begin by Q4 2013. Pfenex is going to assume primary ...
    4-16-2013
  • Pfenex Division Begins Product Capacity Expansion
    capacity will be in excess of 50 kilograms of cGMP grade CRM197, according to Pfenex. ... currently being developed by its partners, explained Bertrand Liang, Ph.D., CEO of Pfenex. ...
    1-16-2013
  • Twisting and Turning for Better Protein Expression
    ... Parallel Processing The Pfenex Pseudomonas fluorescens -based expression platform is well-known. Pfenex produces difficult-to-express proteins by applying "parallel processing" to ...
    1-1-2013
  • People in the News
    Orgenesis appointed Camillo Ricordi, M.D. , to its scientific advisory board...ImmunoGen hired Charles Morris as evp and chief development officer... Kristi Sarno joined Pfenex as ...
    1-1-2013
  • Recombinant Production of Carrier Proteins
    ... Pfenex has developed a process to produce high levels of CRM 197 using a BSL-1 P. fluorescens production strain and also filed a Biologics Master File at the U.S. FDA. Pfenex ...
    12-1-2012
  • Needle-Free Anthrax Vaccine Wins NIAID Contract
    Pfenex won a National Institute of Allergy and Infectious Diseases (NIAID) contract worth an initial $2.18 million to support development of a dry formulation of the firm's Pfenex-...
    10-17-2012
  • Virtual Companies' Benefits, and Costs, All Too Real
    ... marketing and business development with Pfenex. Rubicon is in talks with Pfenex, which Brady said is drawing a growing number of virtuals among current and prospective customers. ...
    9-11-2012
  • Pfenex, DNA2.0 Ally to Improve Protein Expression Technology
    Pfenex and DNA2.0 have entered an R&D agreement for genes to be expressed by Pfenex Expression Technology. DNA2.0 will develop an optimized algorithm and process for the design and ...
    3-1-2012
  • Recombinant Protein Expression Advances
    screen strains as part of the high-throughput process of the Pfenex technology platform. ... A protein expression platform created by Pfenex that is based on the Pseudomonas ...
    9-15-2011
  • Achieving Optimal Expression for Fabs
    What has been needed is a way to apply parallel processing to expression strain development so that multiple expression strategies can be accessed and tested simultaneously. Pfenex ...
    7-1-2011
  • Nudging Difficult-to-Express Proteins
    ... developed by Pfenex, yielded a properly folded, biologically active dimer. "That confirmed that we had a difficult-to-express molecule," he noted. Pfenex can create over ...
    6-15-2011
  • Pfenex to Supply Henry M. Jackson Foundation with Carrier Protein...
    In addition, Pfenex will grant HJF access to a biologics master file that will be filed ... Pfenex has developed a recombinantly produced form and is making it available to vaccine ...
    11-30-2010
  • Expression System Re-Targeted to Discovery
    Pfenex System Repositioned to Support Early-Stage Research Pfenex expression technology can be applied across the product-development continuum. Change is under way at Pfenex as ...
    9-1-2010
  • Pfenex Scores Government Contract to Develop Production Process...
    Development Authority (BARDA) has awarded Pfenex a contract for up to $18.8 million ... The contract will support the development of a Pfenex Expression Technology(tm)-based ...
    8-3-2010

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll